Green Cross Medical Science Corporation

GC Medical Science Corporation is a diagnostic medical device company in the in vitro diagnostics industry, based in South Korea with international operations. Its products include human healthcare diagnostics for diabetes, non-communicable diseases, respiratory diseases, and vector-borne diseases, such as CERA-CHEK 1Code and CERA-CHEK 1070 for diabetes, GREENCARE A1c for HbA1c, CERA-CHEK 3 in 1 GHL for multi-diagnosis, CERA-CHEK Lactate, GREENCARE Hb and CERA-CHEK Hb Plus for haemoglobin, and GCare Lipid and GCare Lipid Printer for cholesterol. The company also offers Covid-19 and flu diagnostic equipment including GENEDIA W Covid-19 Ag, GreenCare FLU2 Influenza A&B Ag, and GENEDIA W Covid-19 & Flu A&B Ag, as well as dengue diagnostic equipment such as GENEDIA W Dengue NS1 Ag, GENEDIA W Dengue lgM/lgG Ab, and GENEDIA W Dengue NS1 & lgM/lgG Combo. Additionally, it provides veterinary healthcare products including the CERA-PET blood glucose monitoring system for diabetes and CERA-PET Multi for non-communicable disease diagnosis. The company was formerly known as Green Cross Medical Science Corporation and changed its name to GC Medical Science Corporation in May 2026. It was founded in 1972 and is headquartered in Yongin-Si, South Korea.